Silencing microRNA-16 induces drug resistance of hepatoma cell lines via nuclear factor-κB pathway

Yingbin Huang,Guangyu Chen,Yang Wang,Rui He,Jun Du,Xingyuan Jiao,Qiang Tai
DOI: https://doi.org/10.3760/cma.j.issn.1001-9030.2018.09.021
2018-01-01
Abstract:Objective Study on the mechanism of sliencing microRNA (miRNA,miR)-16 on chemoresistance in SMMC-7721.Methods The lentiviral vectors were used to construct stable cell lines.To determine whether constructed successfully,the expression of miR-16 was detected by real-time reverse transcription-polymerase chain reaction (RT-qPCR) and inhibitor of kappaB kinase beta (IKBKB),the target gene of miR-16,was detected by Western blotting.The sensitivity and resistance mechanism of the stable cell lines to paclitaxel were detected by Western blotting and thiazole blue (MTT).Results The expression of miR-16 in 7721-miR16 group was significantly higher than SMMC-7721 and 7721-mock groups (4.63 ± 1.32 vs.1.00 ± 0.30 vs.0.93 ± 0.37,P =0.000).The expression of IKBKB in 7721-shmiR16 was 25.73 times than the controls (P =0.000).The expression of multidrug resistance protein 1 (MDR1) in 7721-shmiR16 was increased and the half maximal inhibitory concentration (IC50) to paclitaxel was 4.903 μmol/L,10.64 times than the control group (0.461 μmol/L) (P =0.000).The results of western showed that silencing miR-16 induced resistance mainly through activating nuclear factor-kappaB (NF-κB) pathway.Conclusion Silencing miR-16 in SMMC-7721 significantly increases IKBKB expression leadind paclitaxel resistance.
What problem does this paper attempt to address?